Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICA: Mipomersen in Severe LDL-Hypercholesterolemia on Apheresis
NCT01598948Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Aug 2012
- Primary completion
- May 2015
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 1
01
Overview
A Phase 3 trial of mipomersen in hypercholesterolemia, sponsored by Ludwig Maximilian University of Munich. Started Aug 2012; status: completed.
02
Drugs
mipomersen
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01598948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01598948.